Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 09, 2015 09:26 ET | Source: Macrocure

Macrocure Announces Annual General Meeting of Shareholders

PETACH TIKVA, Israel, Dec. 9, 2015 (GLOBE NEWSWIRE) -- Macrocure Ltd. (NASDAQ:MCUR), a clinical-stage biotechnology company, today announced that it will hold its Annual General Meeting of...
November 27, 2015 13:05 ET | Source: Macrocure

Macrocure Ltd. Reports Changes to Senior Management and the Board of Directors

PETACH TIKVA, Israel, Nov. 27, 2015 (GLOBE NEWSWIRE) -- Macrocure Ltd. ("Macrocure" or the "Company") (NASDAQ:MCUR), today announced that as the Company continues to explore potential strategic...
November 17, 2015 16:05 ET | Source: Macrocure

Macrocure Ltd. Reports Third Quarter 2015 Financial Results

PETACH TIKVA, Israel, Nov. 17, 2015 (GLOBE NEWSWIRE) -- Macrocure Ltd. ("Macrocure" or the "Company") (NASDAQ:MCUR), today provided a corporate update and reported financial results for the third...
October 27, 2015 17:20 ET | Source: Macrocure

Macrocure Ltd. Announces Results for Phase III Clinical Trial of CureXcell(R) in Diabetic Foot Ulcers and Provides Corporate Update

PETACH TIKVA, Israel, Oct. 27, 2015 (GLOBE NEWSWIRE) -- Macrocure Ltd. ("Macrocure" or the "Company") (NASDAQ:MCUR), a clinical-stage biotechnology company focused on advancing its novel therapeutic...
August 19, 2015 18:40 ET | Source: Macrocure

Macrocure Ltd. Provides Update on Futility Analysis for Phase III Clinical Trial of CureXcell(R) in Venous Leg Ulcers

PETACH TIKVA, Israel, Aug. 19, 2015 (GLOBE NEWSWIRE) -- Macrocure Ltd. ("Macrocure" or the "Company") (NASDAQ:MCUR), a clinical-stage biotechnology company focused on advancing its novel therapeutic...
August 04, 2015 16:05 ET | Source: Macrocure

Macrocure Ltd. Provides Corporate Update and Reports Second Quarter 2015 Financial Results

—Company to Report VLU Futility Analysis Results in the Second Half of August 2015— —Company to Report Top Line Results From Its Phase III Diabetic Foot Ulcer (DFU) in October...
July 22, 2015 08:00 ET | Source: Macrocure

Macrocure Ltd. Announces Second Quarter 2015 Financial Results Date and Conference Call

PETACH TIKVA, Israel, July 22, 2015 (GLOBE NEWSWIRE) -- Macrocure Ltd. (NASDAQ:MCUR), a clinical-stage biotechnology company focused on developing a novel therapeutic platform to address chronic and...
May 29, 2015 08:00 ET | Source: Macrocure

Macrocure Ltd. to Present at the Jefferies 2015 Global Healthcare Conference

PETACH TIKVA, Israel, May 29, 2015 (GLOBE NEWSWIRE) -- Macrocure Ltd. (Nasdaq:MCUR), a clinical-stage biotechnology company focused on developing a novel therapeutic platform to address chronic and...
May 11, 2015 16:05 ET | Source: Macrocure

Macrocure Ltd. Provides Corporate Update and Reports First Quarter 2015 Financial Results

PETACH TIKVA, Israel, May 11, 2015 (GLOBE NEWSWIRE) -- Macrocure Ltd. ("Macrocure" or "the Company") (Nasdaq:MCUR), a clinical-stage biotechnology company focused on developing a novel therapeutic...
May 04, 2015 16:05 ET | Source: Macrocure

Macrocure Files Annual Report on Form 20-F for the Year Ended December 31, 2014

PETACH TIKVA, Israel, May 4, 2015 (GLOBE NEWSWIRE) -- Macrocure Ltd. (Nasdaq:MCUR), a clinical stage biotechnology company focused on developing a novel therapeutic platform to address chronic and...